SCHEMBL3829792

SCHEMBL3829792

CC(=O)NC(=Cc1cc(C)c(OCc2ccccc2)c(C)c1)C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MCL1 Q07820 1/20 0.56
▸ RECQL P46063 1/20 0.55
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ PTPN1 P18031 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ BRD4 O60885 1/20 0.41
▸ PTGER4 P35408 3/20 0.40
▸ PTGER3 P43115 3/20 0.40
▸ PTGER2 P43116 3/20 0.40
▸ PTGER1 P34995 2/20 0.40
▸ GSK3B P49841 1/20 0.40
▸ BACE1 P56817 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ NR1H4 Q96RI1 1/20 0.39
▸ TAOK1 Q7L7X3 1/20 0.39
▸ TAOK3 Q9H2K8 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3520402 0.92 RECQL (0.53) MCL1RECQLMEN1KMT2APTPN1
SCHEMBL3520399 0.92 RECQL (0.53) MCL1RECQLMEN1KMT2APTPN1
SCHEMBL3520400 0.92 RECQL (0.53) MCL1RECQLMEN1KMT2APTPN1
SCHEMBL2087310 0.91 MCL1 (0.66) MCL1RECQLMEN1KMT2AHPGD
SCHEMBL2087308 0.91 MCL1 (0.66) MCL1RECQLMEN1KMT2AHPGD
SCHEMBL2086975 0.91 MEN1 (0.51) MCL1RECQLMEN1KMT2APTPN1
SCHEMBL2086974 0.91 MEN1 (0.51) MCL1RECQLMEN1KMT2APTPN1
SCHEMBL27667677 0.84 MCL1 (0.43) MCL1RECQLMEN1KMT2APTPN1
SCHEMBL1206157 0.83 MCL1 (0.57) MCL1RECQLMEN1KMT2APTPN1
SCHEMBL3517579 0.83 MCL1 (0.57) MCL1RECQLMEN1KMT2APTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1732917-B8 SELECTED CGRP ANTAGONISTS, METHODS FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS BOEHRINGER INGELHEIM INT (DE) 2009-09-09 — — EP disclosed
EP-1732917-A1 SELECTED CGRP ANTAGONISTS, METHODS FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS Boehringer Ingelheim International GmbH (DE) 2006-12-20 — — EP disclosed
WO-2005092880-A1 SELECTED CGRP ANTAGONISTS, METHODS FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-10-06 — — WO disclosed
Send feedback